All orthostatic hypotension is neurogenic

El-Bedawi KM, Hainsworth R (1994) Combined head-up tilt and lower body suction: a test of orthostatic tolerance. Clin Auton Res 4(1–2):41–47 Gamboa A et al (2008) Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension 51(6):1531–1536 Okamoto LE et al (2021) Local passive heat for the treatment of hypertension in autonomic failure. J Am Heart Assoc 10(7):e018979 Vogel ER, Sandroni P, Low PA (2005) Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology 65(10):1533–1537 Low P, Singer W (2023) The arterial baroreflex in neurogenic orthostatic hypotension. Clin Auton Res 33(2):81–82 Norcliffe-Kaufmann L et al (2018) Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 83(3):522–531 Juraschek SP et al (2020) Orthostatic hypotension, cardiovascular outcomes, and adverse events: results from SPRINT. Hypertension 75(3):660–667 Kaufmann H et al (2014) Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 83(4):328–335 Singer W et al (2006) Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 63(4):513–518 Mar PL et al (2015) Neurogenic hyperadrenergic orthostatic hypotension: a newly recognized variant of orthostatic hypotension in older adults with elevated norepinephrine (noradrenaline). Clin Sci (Lond) 129(2):107–116 Shibao C et al (2013) Early discontinuation of treatment in patients with orthostatic hypotension. Auton Neurosci 177(2):291–296 Shibao CA et al (2020) Congenital absence of norepinephrine due to CYB561 mutations. Neurology 94(2):e200–e204 Wahba A et al (2022) Management of orthostatic hypotension in the hospitalized patient: a narrative review. Am J Med 135(1):24–31